المؤلفون: Zhongzhao Wang, Yang Luo, Heng Gong, Yang Chen, Hao Tang

المصدر: Discover Oncology, Vol 15, Iss 1, Pp 1-6 (2024)

مصطلحات موضوعية: ALK fusion, Brigatinib, PLEKHA7-ALK, EML4-ALK, NGS, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2730-6011

URL الوصول: https://doaj.org/article/574008b1f2334b3f99ae4d37449cd8f5

المؤلفون: Yang Zhang, Ke-jie Li, Can Wang, Chang-lin Zou, Meng Su

المصدر: Frontiers in Oncology, Vol 14 (2025)

مصطلحات موضوعية: XPO1-ALK, brigatinib, lung adenocarcinoma, targeted therapy, case report, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2024.1503262/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/52f74c98e59744c99bcaa7e30b89618d

المؤلفون: Blerina Resuli, Heidi Galarza, Laura Elsner, Diego Kauffmann-Guerrero, Jürgen Behr, Amanda Tufman

المصدر: Respiratory Medicine Case Reports, Vol 53, Iss , Pp 102160- (2025)

مصطلحات موضوعية: Alectinib, Brigatinib, NSCLC, Pneumonitis, Case report, Diseases of the respiratory system, RC705-779

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2213007124001837; https://doaj.org/toc/2213-0071

URL الوصول: https://doaj.org/article/35fb2df8e7004331a253992864a5926b

المؤلفون: Yuki Sato, Yoshiharu Sato, Kei Irie, Shigeki Nanjo, Shigeo Hara, Satoru Fujiwara, Keisuke Tomii

المصدر: Thoracic Cancer, Vol 15, Iss 23, Pp 1772-1775 (2024)

مصطلحات موضوعية: ALK, brigatinib, CNS penetration, lorlatinib, non‐small cell lung cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1759-7706; https://doaj.org/toc/1759-7714

URL الوصول: https://doaj.org/article/9dda332cfb6e4c8c9d4fe688ccdf5463

المؤلفون: Waleed Kian, Belal Krayim, Betsy Giles, Nasim A. Elkiaan, Amjad Idris, Daniel Fink, Nir Peled, Laila C. Roisman

المصدر: Frontiers in Oncology, Vol 14 (2024)

مصطلحات موضوعية: brigatinib, osimertinib, neoadjuvant, ALK, EGFR, lung cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2024.1286116/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/d63d6b099fac4d74a9cb497e63f4c04c

المؤلفون: Gettinger, Scott N, Huber, Rudolf M, Kim, Dong-Wan, Bazhenova, Lyudmila, Hansen, Karin Holmskov, Tiseo, Marcello, Langer, Corey J, Rodríguez, Luis G Paz-Ares, West, Howard L, Reckamp, Karen L, Weiss, Glen J, Smit, Egbert F, Hochmair, Maximilian J, Kim, Sang-We, Ahn, Myung-Ju, Kim, Edward S, Groen, Harry JM, Pye, Joanna, Liu, Yuyin, Zhang, Pingkuan, Vranceanu, Florin, Camidge, D Ross

المصدر: JTO Clinical and Research Reports. 3(9)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Trials and Supportive Activities, Cancer, Clinical Research, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, 6.2 Cellular and gene therapies, ALK tyrosine kinase inhibitor, Anaplastic lymphoma kinase, Brigatinib, Crizotinib, Non–small-cell lung cancer

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/9wr5984c
https://escholarship.org/content/qt9wr5984c/qt9wr5984c.pdf

المؤلفون: Hayoung Seong, Soo Han Kim, Mi Hyun Kim, Jeong Su Cho, Ahrong Kim, Jung Seop Eom

المصدر: Frontiers in Oncology, Vol 14 (2024)

مصطلحات موضوعية: lung cancer, anaplastic lymphoma kinase-tyrosine kinase inhibitor, brigatinib, neoadjuvant treatment, case report, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2024.1343238/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/be35cbc2a95040a5aa665878d0728119

المؤلفون: Jeong Eun Lee, Jin Hyun Nam, Sun Hong Kwon, Bo Kyung Kim, Seung Min Ha

المصدر: Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)

مصطلحات موضوعية: brigatinib, claims data, effectiveness, real‐world evidence, safety, South Korea, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-7634

URL الوصول: https://doaj.org/article/9a35d83a8f3941bb8eec36ec397e0085

المؤلفون: Kei Morikawa, Yu Numata, Yusuke Shinozaki, Shotaro Kaneko, Aya Matsushima, Makoto Nishida, Hirotaka Kida, Hiroshi Handa, Hiroki Nishine, Masamichi Mineshita

المصدر: Thoracic Cancer, Vol 15, Iss 6, Pp 496-499 (2024)

مصطلحات موضوعية: ALK fusion gene‐positive lung cancer, brain metastasis, brigatinib, non‐small cell lung cancer (NSCLC), tyrosine kinase inhibitors (TKIs), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1759-7706; https://doaj.org/toc/1759-7714

URL الوصول: https://doaj.org/article/0860e34e98624a1880da4cf689d2bfb3

المؤلفون: Högnäsbacka, Antonia Alice

المصدر: Högnäsbacka , A A 2024 , ' Development of Small Molecule Positron Emission Tomography Tracers Targeting Mutated Epidermal Growth Factor Receptor Kinase ' , PhD , Vrije Universiteit Amsterdam . https://doi.org/10.5463/thesis.773

مصطلحات موضوعية: EGFR, PET, carbon-11, [11C]osimertinib, [11C]brigatinib, [11C]EAI045

وصف الملف: application/pdf

Relation: urn:ISBN:9789465064956

الاتاحة: https://research.vu.nl/en/publications/0691e2db-ed39-4452-97c6-2082f6b95c8f
https://doi.org/10.5463/thesis.773
https://hdl.handle.net/1871.1/0691e2db-ed39-4452-97c6-2082f6b95c8f
https://research.vu.nl/ws/files/360510088/176733antoniahognasbackabnwdef2dpr%20-%2066fd636c5d6aa.pdf
https://research.vu.nl/ws/files/360510090/176733antoniahognasbackaoms11defdpr%20-%2066fd6388484e1.pdf
https://research.vu.nl/ws/files/360510092/tochognasbacka%20-%2066fe4ccf0e061.pdf
https://research.vu.nl/ws/files/360510094/title%20page%20-%20pdf%20for%20submission%20-%2066c0fdba823dd.pdf

المؤلفون: Cesare Gridelli, Marcello Tiseo, Diego Luigi Cortinovis, Maria Rita Migliorino, Vito Barbieri, Paolo Bironzo, Alessandra Bearz, Ilaria Attili, Filippo de Marinis

المصدر: Current Oncology, Vol 30, Iss 11, Pp 10033-10042 (2023)

مصطلحات موضوعية: lung cancer, ALK, lorlatinib, brigatinib, alectinib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.mdpi.com/1718-7729/30/11/729; https://doaj.org/toc/1198-0052; https://doaj.org/toc/1718-7729

URL الوصول: https://doaj.org/article/54f230401afe47b6b58e03ea5df5f95f

المؤلفون: Kazushige Wakuda, Hirotsugu Kenmotsu, Yuki Sato, Atsushi Nakamura, Hiroaki Akamatsu, Motoko Tachihara, Satoru Miura, Toshihide Yokoyama, Keita Mori, Kazuhiko Nakagawa, Nobuyuki Yamamoto

المصدر: BMC Cancer, Vol 23, Iss 1, Pp 1-6 (2023)

مصطلحات موضوعية: Non-small cell lung cancer, ALK, Brigatinib, Pemetrexed, Chemotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1471-2407

URL الوصول: https://doaj.org/article/d9026cc985de4542a52c71143cb58729

المؤلفون: Dan Li, Yue Zhu, Jincheng Song, Dafu Yang, Saiqiong Cui, Xin Liu, Le Wang, Jiangyan Zhang, Evenki Pan, Zhaoxia Dai

المصدر: Frontiers in Oncology, Vol 14 (2024)

مصطلحات موضوعية: ALK rearrangement, brigatinib, entrectinib, resistance mutations, ETV6-NTRK3, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2024.1339511/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/86d94ff29ae34a21991f4c647c2ab4bb

المؤلفون: Lee AT, Ou SI

المصدر: Lung Cancer: Targets and Therapy, Vol Volume 14, Pp 71-78 (2023)

مصطلحات موضوعية: alesia, crown, alectinib, lorlatinib, brigatinib, pharmacokinetics, dose response, alk fusion, nsclc, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.dovepress.com/alesia-5-year-update-alectinib-at-600-mg-twice-daily-gives-lorlatinib--peer-reviewed-fulltext-article-LCTT; https://doaj.org/toc/1179-2728

URL الوصول: https://doaj.org/article/e380b0df481f4173bf1b2b9bd430add3

المؤلفون: Lee AT, Ou SI

المصدر: Lung Cancer: Targets and Therapy, Vol Volume 14, Pp 57-62 (2023)

مصطلحات موضوعية: alta-3, alur, ascend-5, brigatinib, alectinib, ceritinib, crizotinib, advanced alk+ nsclc, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.dovepress.com/from-ascend-5-to-alur-to-alta-3-an-anti-climactic-end-to-the-era-of-ra-peer-reviewed-fulltext-article-LCTT; https://doaj.org/toc/1179-2728

URL الوصول: https://doaj.org/article/a4920faea99648adaa4cc549408017c6

المؤلفون: Wenjie Liu, Gengwei Huo, Peng Chen

المصدر: Frontiers in Public Health, Vol 12 (2024)

مصطلحات موضوعية: cost-effectiveness analysis, brigatinib, lorlatinib, ALK, non-small cell lung cancer, Public aspects of medicine, RA1-1270

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fpubh.2024.1213318/full; https://doaj.org/toc/2296-2565

URL الوصول: https://doaj.org/article/ea89484ae5b140fa93d58de90a7fee76

المؤلفون: Luca Mastrantoni, Giulia Giordano, Emanuele Vita, Guido Horn, Jacopo Russo, Armando Orlandi, Gennaro Daniele, Diana Giannarelli, Giampaolo Tortora, Emilio Bria

المصدر: Cancer Treatment and Research Communications, Vol 41, Iss , Pp 100842- (2024)

مصطلحات موضوعية: ALK-inhibitors, Alectinib, Lorlatinib, Brigatinib, Ensartinib, LHH, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2468294224000546; https://doaj.org/toc/2468-2942

URL الوصول: https://doaj.org/article/027ba545a3d04abb89e195068dc14876

المؤلفون: Yuichi Ozawa, Yasuhiro Koh, Tetsunari Hase, Kenji Chibana, Kyoichi Kaira, Kyoichi Okishio, Eiki Ichihara, Shuji Murakami, Mototsugu Shimokawa, Nobuyuki Yamamoto

مصطلحات موضوعية: Respiratory Diseases, Oncology and Carcinogenesis not elsewhere classified, Pharmacology and Pharmaceutical Sciences not elsewhere classified, Aged Health Care, alectinib, ALK inhibitors, brigatinib, non-small-cell lung cancer, observational study

Relation: https://figshare.com/articles/journal_contribution/sj-docx-1-tam-10_1177_17588359231225046_Supplemental_material_for_Prospective_observational_study_to_explore_genes_and_proteins_predicting_efficacy_and_safety_of_brigatinib_for_ALK-gene_rearranged_non-small-cell_lung_cancer_study_protocol_f/25097209

الاتاحة: https://doi.org/10.25384/sage.25097209.v1
https://figshare.com/articles/journal_contribution/sj-docx-1-tam-10_1177_17588359231225046_Supplemental_material_for_Prospective_observational_study_to_explore_genes_and_proteins_predicting_efficacy_and_safety_of_brigatinib_for_ALK-gene_rearranged_non-small-cell_lung_cancer_study_protocol_f/25097209

المؤلفون: Gianluca Spitaleri, Pamela Trillo Aliaga, Ilaria Attili, Ester Del Signore, Carla Corvaja, Chiara Corti, Edoardo Crimini, Antonio Passaro, Filippo de Marinis

المصدر: Current Oncology, Vol 30, Iss 5, Pp 5072-5092 (2023)

مصطلحات موضوعية: NSCLC, ALK, ALK inhibitors, alectinib, lorlatinib, brigatinib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.mdpi.com/1718-7729/30/5/384; https://doaj.org/toc/1198-0052; https://doaj.org/toc/1718-7729

URL الوصول: https://doaj.org/article/237f3ac30475444a97d7a0d94817d83b

المؤلفون: Mingyi YANG, Weichi LUO, Qing ZHOU

المصدر: Chinese Journal of Lung Cancer, Vol 26, Iss 4, Pp 281-290 (2023)

مصطلحات موضوعية: lung neoplasms, anaplastic lymphoma kinase, early-onset pulmonary events, brigatinib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1009-3419; https://doaj.org/toc/1999-6187

URL الوصول: https://doaj.org/article/3c809d6d5eb746e48498f8ff93c76c0c